To test this hypothesis, the prognosis of CRC patients was stratified based upon the expression of INSL5 and HCAR3, in all but one case the prognosis was consistent with the expression of INSL5 and HCAR3 (Figure S2). This evidence concerns the gene INSL5 and colorectal carcinoma.